Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 18044983)

1.

Controlling endemic cholera with oral vaccines.

Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD.

PLoS Med. 2007 Nov 27;4(11):e336.

2.

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD.

Lancet. 2005 Jul 2-8;366(9479):44-9.

PMID:
15993232
3.

The case for reactive mass oral cholera vaccinations.

Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L.

PLoS Negl Trop Dis. 2011 Jan 25;5(1):e952. doi: 10.1371/journal.pntd.0000952.

4.

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.

Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, Hang PV, Rao MR.

Lancet. 1997 Jan 25;349(9047):231-5.

PMID:
9014909
5.

Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.

Jeuland M, Cook J, Poulos C, Clemens J, Whittington D; DOMI Cholera Economics Study Group.

Value Health. 2009 Sep;12(6):899-908. doi: 10.1111/j.1524-4733.2009.00562.x.

PMID:
19824189
6.

The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.

Clemens J, Sack D, Rao M, Chakraborty J, Kay B, Ahmed F, Khan MR, van Loon FP, Svennerholm AM, Holmgren J.

Int J Epidemiol. 1993 Aug;22(4):724-30.

PMID:
8225749
7.

Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.

Ali M, Emch M, Yunus M, Sack D, Lopez AL, Holmgren J, Clemens J.

Pediatr Infect Dis J. 2008 Jan;27(1):33-7.

PMID:
18162935
9.

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R.

PLoS Negl Trop Dis. 2012;6(10):e1844. doi: 10.1371/journal.pntd.0001844. Epub 2012 Oct 4.

10.

Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.

Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, Puri M, Wierzba TF, Donner A, Nair GB, Bhattacharya SK, Dhingra MS, Deen JL, Lopez AL, Clemens J.

Clin Infect Dis. 2013 Apr;56(8):1123-31. doi: 10.1093/cid/cit009. Epub 2013 Jan 29.

11.

Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.

Clemens J, Rao M, Sack D, Ahmed F, Khan MR, Chakraborty J, Kay B, Huda S, Yunus M, van Loon F, et al.

Am J Epidemiol. 1995 Oct 1;142(7):759-64.

PMID:
7572947
12.

Field trial of oral cholera vaccines in Bangladesh.

Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, Stanton BF, Kay BA, Khan MU, Yunus M, Atkinson W, et al.

Lancet. 1986 Jul 19;2(8499):124-7.

PMID:
2873397
13.

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.

Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J.

Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.

PMID:
22954655
14.

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

Clemens J, Holmgren J.

Curr Top Microbiol Immunol. 2014;379:231-58. doi: 10.1007/82_2013_353. Review.

PMID:
24402712
15.

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, Clemens JD, Cravioto A, Qadri F.

Vaccine. 2013 Dec 9;31(51):6058-64. doi: 10.1016/j.vaccine.2013.10.021. Epub 2013 Oct 22.

16.

Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.

Emch M, Ali M, Park JK, Yunus M, Sack DA, Clemens JD.

Int J Epidemiol. 2006 Aug;35(4):1044-50. Epub 2006 May 24.

17.

The role of vaccine coverage within social networks in cholera vaccine efficacy.

Root ED, Giebultowicz S, Ali M, Yunus M, Emch M.

PLoS One. 2011;6(7):e22971. doi: 10.1371/journal.pone.0022971. Epub 2011 Jul 29.

18.

Cholera vaccines for the developing world.

Lopez AL, Clemens JD, Deen J, Jodar L.

Hum Vaccin. 2008 Mar-Apr;4(2):165-9. Epub 2007 Oct 7. Review.

19.

Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.

Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B.

Bull World Health Organ. 1999;77(10):837-42.

20.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk